Loading

Press Releases

Press Releases

  1. ProBioGen and Inhibrx Sign License Deal on GlymaxX® ADCC Technology for Therapeutic Antibodies Development

    PDF Download

  2. Boehringer Ingelheim licenses ProBioGen's novel GlymaxX Technology

    PDF Download

  3. ProBioGen and Life Technologies Present Freedom™ CHO-S™ Platform, a Royalty-Free New cGMP Cell Line Development Kit

    PDF Download

  4. ProBioGen Presents GlymaxX - The Novel Glyco-Engineering Technology

    PDF Download

  5. Minapharm Pharmaceuticals acquires majority stake in ProBioGen – Dr. Wieland Wolf appointed new CEO

    PDF Download

  6. AFFiRiS will explore ProBioGen’s Human Artificial Lymph Node Technology for Vaccine Testing

    PDF Download

  7. ProBioGen signs therapeutic protein process development contract with Virdante Pharmaceuticals

    PDF Download

  8. ProBioGen Is Granted Divisional Patent on Its Proprietary AGE1 Cell Line

    PDF Download

  9. ProBioGen Announces the Appointment of Dr. Volker Sandig to Chief Scientific Officer

    PDF Download